STRATA Skin Sciences Statistics
Total Valuation
SSKN has a market cap or net worth of $12.05 million. The enterprise value is $21.47 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SSKN has 4.17 million shares outstanding. The number of shares has increased by 4.45% in one year.
| Current Share Class | 4.17M |
| Shares Outstanding | 4.17M |
| Shares Change (YoY) | +4.45% |
| Shares Change (QoQ) | +15.20% |
| Owned by Insiders (%) | 5.04% |
| Owned by Institutions (%) | 6.37% |
| Float | 1.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.32 |
| Forward PS | 0.33 |
| PB Ratio | 1.29 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.08 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.76.
| Current Ratio | 1.13 |
| Quick Ratio | 0.82 |
| Debt / Equity | 1.76 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.92 |
Financial Efficiency
Return on equity (ROE) is -73.49% and return on invested capital (ROIC) is -13.40%.
| Return on Equity (ROE) | -73.49% |
| Return on Assets (ROA) | -8.85% |
| Return on Capital (ROIC) | -13.40% |
| Revenue Per Employee | $330,051 |
| Profits Per Employee | -$94,778 |
| Employee Count | 99 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 3.28 |
Taxes
| Income Tax | -92,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.67% in the last 52 weeks. The beta is 1.35, so SSKN's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -51.67% |
| 50-Day Moving Average | 3.04 |
| 200-Day Moving Average | 3.51 |
| Relative Strength Index (RSI) | 42.21 |
| Average Volume (20 Days) | 8,125 |
Short Selling Information
The latest short interest is 5,752, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 5,752 |
| Short Previous Month | 6,997 |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 0.44 |
Income Statement
In the last 12 months, SSKN had revenue of $32.68 million and -$9.38 million in losses. Loss per share was -$2.58.
| Revenue | 32.68M |
| Gross Profit | 18.13M |
| Operating Income | -6.19M |
| Pretax Income | -11.46M |
| Net Income | -9.38M |
| EBITDA | -1.17M |
| EBIT | -6.19M |
| Loss Per Share | -$2.58 |
Full Income StatementBalance Sheet
The company has $7.06 million in cash and $16.48 million in debt, giving a net cash position of -$9.42 million or -$2.26 per share.
| Cash & Cash Equivalents | 7.06M |
| Total Debt | 16.48M |
| Net Cash | -9.42M |
| Net Cash Per Share | -$2.26 |
| Equity (Book Value) | 9.34M |
| Book Value Per Share | 2.24 |
| Working Capital | 1.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $856,000 and capital expenditures -$2.85 million, giving a free cash flow of -$1.99 million.
| Operating Cash Flow | 856,000 |
| Capital Expenditures | -2.85M |
| Free Cash Flow | -1.99M |
| FCF Per Share | -$0.48 |
Full Cash Flow StatementMargins
Gross margin is 55.47%, with operating and profit margins of -18.93% and -28.72%.
| Gross Margin | 55.47% |
| Operating Margin | -18.93% |
| Pretax Margin | -29.00% |
| Profit Margin | -28.72% |
| EBITDA Margin | -3.57% |
| EBIT Margin | -18.93% |
| FCF Margin | n/a |